The impact of vaccination and outpatient treatment on the economic burden of Covid-19 in the United States omicron era: a systematic literature review

Vicki Pierrea Evidence Synthesis, Modeling & Communication, Evidera Inc., Bethesda, MD, USA

Florin Draicab Vaccine Clinical Research, Pfizer Inc., New York, NY, USA

Manuela Di Fuscob Vaccine Clinical Research, Pfizer Inc., New York, NY, USA

Jingyan Yangb Vaccine Clinical Research, Pfizer Inc., New York, NY, USA

Solange Nunez-Gonzaleza Evidence Synthesis, Modeling & Communication, Evidera Inc., Bethesda, MD, USA

Joanna Kamara Evidence Synthesis, Modeling & Communication, Evidera Inc., Bethesda, MD, USA

Santiago Lopezb Vaccine Clinical Research, Pfizer Inc., New York, NY, USA

Mary M. Moranb Vaccine Clinical Research, Pfizer Inc., New York, NY, USA

Jennifer Nguyenb Vaccine Clinical Research, Pfizer Inc., New York, NY, USA

Piedad Alvareza Evidence Synthesis, Modeling & Communication, Evidera Inc., Bethesda, MD, USA

Ashley Cha-Silvab Vaccine Clinical Research, Pfizer Inc., New York, NY, USA

Meghan Gavaghanb Vaccine Clinical Research, Pfizer Inc., New York, NY, USA

Alon Yehoshuab Vaccine Clinical Research, Pfizer Inc., New York, NY, USA

Naomi Stapletona Evidence Synthesis, Modeling & Communication, Evidera Inc., Bethesda, MD, USA

Heather Burnetta Evidence Synthesis, Modeling & Communication, Evidera Inc., Bethesda, MD, USACorrespondence[email protected]

Your download is now in progress and you may close this window